Literature DB >> 9856285

The 2-5A system in viral infection and apoptosis.

J Castelli1, K A Wood, R J Youle.   

Abstract

The 2-5A system is an established endogenous antiviral pathway. Interferon treatment of cells leads to an increase in basal, but latent, levels of 2-5A-dependent RNase (RNase L) and the family of 2'-5' oligoadenylate synthetases (OAS). Double-stranded RNA, thought to be derived from viral replication intermediates, activates OAS. Activated OAS converts ATP into unusual short 2'-5' linked oligoadenylates called 2-5A [ppp5'(A2'p5')2A]. The 2-5A binds to and activates RNase L which cleaves single stranded RNA with moderate specificity for sites 3' of UpUp and UpAp sequences, and thus leads to degradation of cellular rRNA. During apoptosis, generalized cellular RNA degradation, distinct from the differential expression of mRNA species that may regulate specific gene expression during apoptosis, has been observed. The mechanism of RNA breakdown during apoptosis has been commonly considered a non-specific event that reflects the generalized shut down of translation and homeostatic regulation during cell death. Due to the similar RNA degradation that occurs during both apoptosis and viral infection we investigated the potential role of RNase L in apoptosis. To investigate whether RNase L activity could lead to apoptosis, NIH3T3 cells were transfected with a lac-inducible vector containing the human RNase L gene. Treatment of these cells with isopropylthiogalactoside (IPTG) caused loss of cell viability that was confirmed as an apoptotic cell death by morphological and biochemical criteria. Similarly, specific allosteric activation of endogenous RNase L by introduction of 2-5A directly into L929 cells also induced apoptosis. In L929 cells poly(I).poly(C) treatment in combination with interferon caused an increase in apoptosis whereas neither interferon or double stranded RNA alone altered cell viability. Therefore, increased expression or activation of RNase L causes apoptosis. Inhibition of RNase L, specifically with a dominant negative mutant, suppressed poly(I)Ypoly(C)-induced apoptosis in interferon-primed fibroblasts. Poliovirus, a picornovirus with a single-stranded RNA genome, causes apoptosis of HeLa cells. Expression of the dominant negative inhibitor of RNase L in HeLa prevented virus-induced apoptosis and maintained cell viability. Thus, reduction or inhibition of RNase L activity prevents apoptosis. Both apoptosis and the 2-5A system can provide defense against viral infection in multicellular organisms by preventing production and therefore spread of progeny virus. RNase L appears to function in both mechanisms, therefore, initiation of apoptosis may be one mechanism for the antiviral activity of the 2-5A system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856285     DOI: 10.1016/s0753-3322(99)80006-7

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  27 in total

1.  Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.

Authors:  Annika Rökman; Tarja Ikonen; Eija H Seppälä; Nina Nupponen; Ville Autio; Nina Mononen; Joan Bailey-Wilson; Jeffrey Trent; John Carpten; Mika P Matikainen; Pasi A Koivisto; Teuvo L J Tammela; Olli-P Kallioniemi; Johanna Schleutker
Journal:  Am J Hum Genet       Date:  2002-04-08       Impact factor: 11.025

2.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways.

Authors:  Yin Chen; Edward Hamati; Pak-Kei Lee; Wai-Ming Lee; Shinichiro Wachi; David Schnurr; Shigeo Yagi; Gregory Dolganov; Homer Boushey; Pedro Avila; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2005-10-06       Impact factor: 6.914

3.  Noncytopathic bovine viral diarrhea virus inhibits double-stranded RNA-induced apoptosis and interferon synthesis.

Authors:  M Schweizer; E Peterhans
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.

Authors:  Alexei V Evsikov; Joel H Graber; J Michael Brockman; Ales Hampl; Andrea E Holbrook; Priyam Singh; John J Eppig; Davor Solter; Barbara B Knowles
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

Review 5.  Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control.

Authors:  Jorge Andrés Castillo Ramirez; Silvio Urcuqui-Inchima
Journal:  J Interferon Cytokine Res       Date:  2015-01-28       Impact factor: 2.607

6.  Immune activation and target organ damage are consequences of hydrodynamic treatment but not delivery of naked siRNAs in mice.

Authors:  Zsuzsanna Rácz; Mária Godó; Csaba Révész; Péter Hamar
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

7.  A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Authors:  Jonathan D Schoenfeld; Danielle N Margalit; Julie L Kasperzyk; Irene M Shui; Jennifer R Rider; Mara M Epstein; Allison Meisner; Stacey A Kenfield; Neil E Martin; Paul L Nguyen; Philip W Kantoff; Edward L Giovannucci; Meir J Stampfer; Lorelei A Mucci
Journal:  Clin Cancer Res       Date:  2013-02-04       Impact factor: 12.531

8.  Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.

Authors:  L Dillon Birdwell; Zachary B Zalinger; Yize Li; Patrick W Wright; Ruth Elliott; Kristine M Rose; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

9.  Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.

Authors:  Marvin Rubenstein; Paulus Tsui; Patrick Guinan
Journal:  Med Oncol       Date:  2007-10-30       Impact factor: 3.064

10.  Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.

Authors:  Marvin Rubenstein; Paulus Tsui; Patrick Guinan
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.